PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Combination therapy does not improve ability to quit smoking after 1 year

2014-01-08
(Press-News.org) Contact information: Kelley Luckstein
luckstein.kelley@mayo.edu
507-284-5005
The JAMA Network Journals
Combination therapy does not improve ability to quit smoking after 1 year Among cigarette smokers, the combined use of the smoking cessation medications varenicline and bupropion, compared with varenicline alone, resulted in better rates of smoking abstinence at 12 weeks, but rates were similar after one year, according to a study in the January 8 issue of JAMA.

Smoking accounts for 62 percent of deaths among female smokers and 60 percent of deaths among male smokers. Innovative pharmacotherapeutic approaches to tobacco-dependence treatment need investigation to reduce smoking-related death and disability, according to background information in the article. "Exploration of combination therapy with existing drugs may provide the best opportunity to advance treatment in the absence of any new pharmacotherapies for tobacco dependence."

Jon O. Ebbert, M.D., M.Sc., of the Mayo Clinic, Rochester, Minn., and colleagues investigated the efficacy of combination pharmacotherapy with varenicline and bupropion SR (sustained-release) for smoking cessation, compared with varenicline alone (monotherapy). The trial included 315 adults who completed the study. Participants were randomized to 12 weeks of varenicline and bupropion SR or varenicline and placebo. There was follow-up through week 52.

The primary outcome was abstinence rates at week 12, defined as prolonged abstinence (no smoking from 2 weeks after the target quit date) and 7-day point-prevalence abstinence (no smoking past 7 days). Outcomes were biochemically confirmed.

Combination therapy was associated with significantly higher prolonged smoking abstinence rates at 12 (53.0 percent vs. 43.2 percent) and 26 weeks (36.6 percent vs. 27.6 percent) compared with varenicline alone. No significant differences were observed in prolonged smoking abstinence rates between the 2 groups at 52 weeks (30.9 percent vs. 24.5 percent).

No significant differences were observed between the 2 groups at any time point for 7-day point-prevalence smoking abstinence rates.

Anxiety was reported more commonly with combination therapy than with varenicline monotherapy (7.2 percent vs. 3.1 percent), as were depressive symptoms (3.6 percent vs. 0.8 percent).

"Among cigarette smokers, combined use of varenicline and bupropion, compared with varenicline alone, resulted in an increase in prolonged abstinence but not 7-day point-prevalence at 12 and 26 weeks; neither outcome was significantly different at 52 weeks. Further research is required to determine the role of combination treatment in smoking cessation," the authors conclude. ###(doi:10.1001/jama.2013.283185; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: The clinical trial was supported by a National Institutes of Health grant (primary investigator, Dr. Ebbert). Medication (varenicline) was provided by Pfizer. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.


ELSE PRESS RELEASES FROM THIS DATE:

Longer-term use of smoking cessation medication effective among patients with mental illness

2014-01-08
Longer-term use of smoking cessation medication effective among patients with mental illness Among smokers with schizophrenia or bipolar disease who achieved initial smoking abstinence with a standard 12-week course of the smoking cessation drug varenicline, an additional ...

Study examines prevalence of smoking among health care professionals

2014-01-08
Study examines prevalence of smoking among health care professionals A survey of health care professionals finds that in 2010-2011, current smoking among this group, except for licensed practical nurses, was lower than the general population, and that the majority ...

Unique protein interaction may drive most common genetic cause of Parkinson's disease

2014-01-08
Unique protein interaction may drive most common genetic cause of Parkinson's disease Gladstone findings challenge conventional wisdom; point to new therapeutic strategies San Francisco, CA—January 7, 2013—The most devastating aspect of Parkinson's disease ...

Survival protein a potential new target for many cancers

2014-01-08
Survival protein a potential new target for many cancers Walter and Eliza Hall Institute researchers have discovered a promising strategy for treating cancers that are caused by one of the most common cancer-causing changes in cells. The discovery offers ...

Fit teenagers are less likely to have heart attacks in later life

2014-01-08
Fit teenagers are less likely to have heart attacks in later life Researchers in Sweden have found an association between a person's fitness as a teenager and their risk of heart attack in later life. In a study of nearly 750,000 men, they found that the more aerobically ...

Fight or flight and the evolution of pain

2014-01-08
Fight or flight and the evolution of pain Recent highlights in Molecular Biology and Evolution Hard wired into the survival mechanisms of all animals is the perception of pain. Different stimuli, such as heat or cold, foul odors, ...

Mega-landslide in giant Utah copper mine may have triggered earthquakes

2014-01-08
Mega-landslide in giant Utah copper mine may have triggered earthquakes January 2014 GSA Today science article Boulder, Colorado, USA – Landslides are one of the most hazardous aspects of our planet, causing billions of dollars in damage and thousands of deaths each year. ...

Of lice and men (and chimps): Study tracks pace of molecular evolution

2014-01-08
Of lice and men (and chimps): Study tracks pace of molecular evolution CHAMPAIGN, Ill. — A new study compares the relative rate of molecular evolution between humans and chimps with that of their lice. The researchers wanted to know whether evolution ...

Is multitasking mastery in the genes?

2014-01-08
Is multitasking mastery in the genes? Human factors/ergonomics researchers have long studied the connection between cognitive function and the ability to perform well on multiple simultaneous tasks, and recently a group of neuroergonomics researchers went a ...

Childhood fractures may indicate bone-density problems

2014-01-08
Childhood fractures may indicate bone-density problems ROCHESTER, Minn. — Broken bones may seem like a normal part of an active childhood. About 1 in 3 otherwise healthy children suffers a bone fracture. Breakage of the bone running from the elbow to the thumb side of the ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Combination therapy does not improve ability to quit smoking after 1 year